吉貝爾(688566.SH):2024年度淨利潤2.19億元,同比降低0.08%
格隆匯2月27日丨吉貝爾(688566.SH)公佈2024年度業績快報,報告期內,公司實現營業總收入8.97億元,同比增加4.14%;歸屬於母公司所有者的淨利潤2.19億元,同比降低0.08%。
影響經營業績的主要因素:1、公司持續強化團隊建設和市場開發,營業總收入、營業利潤實現小幅增長,其中尼羣洛爾片實現銷售收入12,731.06萬元(未經審計,最終數據以年度報告披露爲準),同比增長41.46%;2、公司基於謹慎性原則,對部分長期股權投資等資產計提減值準備;3、公司積極推進抗抑鬱新藥JJH201501、抗腫瘤新藥JJH201601等新藥的研發進程,研發投入增加,其中抗抑鬱新藥JJH201501正在開展III期臨牀試驗,抗腫瘤新藥JJH201601正在開展IIa期臨牀試驗,公司對滿足資本化條件的開發支出進行資本化處理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.